SCHEDULE 13D/A
SCHEDULE 13D/ASchedule 13D ownership disclosure
VERONA PHARMA PLC
Ordinary Shares, nominal value 0.05 GBP · CUSIP: 925050106
Event date: 2025-01-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Growth Equity Opportunities 17, LLCReported CIK 0001790256
Shares: 32,678,025.00 · Class: 4.99%
- New Enterprise Associates 17, L.P.Reported CIK 0001768564
Shares: 32,678,025.00 · Class: 4.99%
- NEA Partners 17, L.P.Reported CIK 0001796820
Shares: 32,678,025.00 · Class: 4.99%
- NEA 17 GP, LLCReported CIK 0001796821
Shares: 32,678,025.00 · Class: 4.99%
- Growth Equity Opportunities Fund IV, LLCReported CIK 0001644965
Shares: 32,678,025.00 · Class: 4.99%
- New Enterprise Associates 15, L.P.Reported CIK 0001629794
Shares: 32,678,025.00 · Class: 4.99%
- NEA Partners 15, L.P.Reported CIK 0001640031
Shares: 32,678,025.00 · Class: 4.99%
- NEA 15 GP, LLCReported CIK 0001640033
Shares: 32,678,025.00 · Class: 4.99%
- Forest BaskettReported CIK 0001277631
Shares: 32,678,025.00 · Class: 4.99%
- Ali BehbahaniReported CIK 0001613867
Shares: 25,541,720.00 · Class: 3.90%
- Carmen ChangReported CIK 0001746342
Shares: 25,541,648.00 · Class: 3.90%
- Anthony A. Florence, Jr.Reported CIK 0001559827
Shares: 32,678,025.00 · Class: 4.99%
- Mohamad H. MakhzoumiReported CIK 0001630226
Shares: 32,678,393.00 · Class: 4.99%
- Edward T. MathersReported CIK 0001328625
Shares: 25,541,720.00 · Class: 3.90%
- Scott D. SandellReported CIK 0001237289
Shares: 32,679,649.00 · Class: 4.99%
- Paul WalkerReported CIK 0001553150
Shares: 25,541,720.00 · Class: 3.90%
- Rick YangReported CIK 0001851328
Shares: 25,541,584.00 · Class: 3.90%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-25-000057
- Form type
- SCHEDULE 13D/A
- Filer
- Growth Equity Opportunities Fund IV, LLC
- CIK
- CIK 1644965
- Filed
- Jan 21, 2025
- Reporting period
- Jan 16, 2025
- Description
- Schedule 13D beneficial ownership